Sharonne Holtzman
Papers
1
Total Citations
12
H-Index
1
About
Sharonne Holtzman is a rising leader in gynecologic oncology whose research focuses on refining surgical management and improving outcomes for patients with endometrial cancer. Her most cited work, a 2023 study comparing sentinel lymph node assessment to full lymphadenectomy in high-risk endometrial cancer, has already garnered 12 citations, signaling its immediate impact on clinical practice. This research challenges traditional surgical dogma by demonstrating that less invasive sentinel node biopsy may offer comparable oncologic safety while reducing morbidity—a pivotal contribution to the field’s shift toward precision surgery. Holtzman’s work sits at the intersection of surgical innovation and patient-centered care, addressing critical questions about risk stratification and treatment de-escalation. Her findings have been presented at major oncology meetings and are influencing guidelines for managing high-risk disease. As a researcher, she is known for translating complex surgical data into actionable insights, making her a valuable voice in the ongoing debate over optimal lymph node management. With a growing portfolio of studies on endometrial cancer outcomes, Holtzman is poised to shape the next generation of evidence-based gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1